FOXD2 and nonpapillary renal cell carcinoma: We found that FOXD2-AS1 was present at high levels in ccRCC cells, indicating that FOXD2-AS1 is a potential target of cuproptosis in ccRCC, and that its mechanism is associated with signal alteration in the tumor microenvironment.